OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Degradation of Hexokinase 2 Blocks Glycolysis and Induces GSDME-Dependent Pyroptosis to Amplify Immunogenic Cell Death for Breast Cancer Therapy
Ruoxi Sang, Renming Fan, Aohua Deng, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8464-8483
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Thermal Proteome Profiling Strategy Identifies CNPY3 as a Cellular Target of Gambogic Acid for Inducing Prostate Cancer Pyroptosis
Xiaowen Zhang, Ling Li, Min Liao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 12, pp. 10005-10011
Closed Access | Times Cited: 17

ASF1A-dependent P300-mediated histone H3 lysine 18 lactylation promotes atherosclerosis by regulating EndMT
Mengdie Dong, Yunjia Zhang, Minghong Chen, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 3027-3048
Open Access | Times Cited: 12

Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy
Xuan Ni, Chengpiao Lu, Guo-qiang Xu, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 8, pp. 1533-1555
Closed Access | Times Cited: 10

Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer
Xin Jin, Wenke Jin, L. Tong, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2815-2853
Open Access | Times Cited: 8

Targeting the mevalonate pathway potentiates NUAK1 inhibition-induced immunogenic cell death and antitumor immunity
Liming Gui, Kaiwen W. Chen, Jingjing Yan, et al.
Cell Reports Medicine (2025), pp. 101913-101913
Open Access | Times Cited: 1

Construction and in vitro evaluation of pH-sensitive nanoparticles to reverse drug resistance of breast cancer stem cells
Weinan Li, Yuhan Fu, Jialin Sun, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6

Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders
Nisha Setia, Haider Thaer Abdulhameed Almuqdadi, Mohammad Abid
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116041-116041
Closed Access | Times Cited: 14

Activation of mTOR/HK2 Signaling Mitigates Effects of PYCR2 Depletion in Colorectal Cells
Li Chen, Yuan Yuan, Nian Zhang, et al.
Tissue and Cell (2025) Vol. 93, pp. 102729-102729
Open Access

Carbohydrate kinase inhibition: a promising strategy in cancer treatment
Amita Jain, Rudradip Das, Monalisha Giri, et al.
Drug Discovery Today (2025), pp. 104308-104308
Closed Access

The Significance of Microenvironmental and Circulating Lactate in Breast Cancer
Vincenza Frisardi, Simone Canovi, Salvatore Vaccaro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15369-15369
Open Access | Times Cited: 11

Discovery of novel quinoline scaffold selective estrogen receptor degraders (SERDs) for treatment of ER positive breast cancer with enhanced antiproliferative bioactivity through immunogenic cell death (ICD) effects
Yunlong Lu, Zhenlin Liang, Lijuan Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116534-116534
Closed Access | Times Cited: 3

Paclitaxel-resistance facilitates glycolytic metabolism via Hexokinase-2-regulated ABC and SLC transporter genes in ovarian clear cell carcinoma
Tsai‐Yu Lin, Shin‐Yuan Gu, Yi-Hui Lin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117452-117452
Open Access | Times Cited: 2

Pyroptosis: Induction and inhibition strategies for immunotherapy of diseases
Junjun Wu, Hong Wang, Pu Gao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4195-4227
Open Access | Times Cited: 1

Decoding cell death signalling: Impact on the response of breast cancer cells to approved therapies
Lama Lozon, Wafaa S. Ramadan, Rawan R. Kawaf, et al.
Life Sciences (2024) Vol. 342, pp. 122525-122525
Closed Access | Times Cited: 1

Discovery of novel KSP-targeting PROTACs with potent antitumor effects in Vitro and in Vivo
Deng‐Gao Zhao, J. Y. Liu, Zhiguang Su, et al.
European Journal of Medicinal Chemistry (2024) Vol. 282, pp. 117052-117052
Closed Access | Times Cited: 1

Cascaded Antitumor Therapy Excited by Dual Nanozymes Based on Energy Restriction and Photocatalysis
Zhuo Li, Jiaxin Bian, Zichuang Xu, et al.
ACS Applied Materials & Interfaces (2023)
Closed Access | Times Cited: 3

Targeting mitochondrial damage: shining a new light on immunotherapy
Wenjuan Zeng, Menghui Wang, Yuxin Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

Research progress on the effect of pyroptosis on the occurrence, development, invasion and metastasis of colorectal cancer
Xu Wang, Qi-Hang Yin, Lin-Lu Wan, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 8, pp. 3410-3427
Open Access

Comprehensive review of drug-mediated ICD inhibition of breast cancer: mechanism, status, and prospects
Yang Wang, Rui Yang, Ying Xie, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top